Center Star Asset Management, LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Center Star Asset Management, LLC

  • $63.5 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Oct 26, 2020
SELL
$255.65 - $303.1 $587,995 - $697,130
-2,300 Closed
0 $0
Q2 2020

Aug 05, 2020
BUY
$225.48 - $295.8 $180,384 - $236,640
800 Added 53.33%
2,300 $47,000
Q1 2020

Apr 13, 2020
BUY
$199.77 - $247.81 $299,655 - $371,715
1,500 New
1,500 $17,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email